title: Citicoline: pharmacological and clinical review, 2010 update.
abstract: This review is based on the previous one published in 2006 -Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 2006; 28 (Suppl B): S1-56-, incorporating the new references until now, having all the information available to facilitate the access to the informacion in one document. This review is focused on the main indications of the drug, as acute stroke and its sequelae, including the cognitive impairment, and traumatic brain injury and its sequelae. There are retrieved the most important experimental and clinical data in both indications.
authors: Medical Department, Grupo Ferrer, SA, Barcelona, Spain. jsecades@ferrergrupo.com
authors: J J
authors: JJ
authors: Secades
mesh_terms: D001930:Brain Injuries / Q000188:drug therapy; D002545:Brain Ischemia / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000188:drug therapy; D003566:Cytidine Diphosphate Choline / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D007858:Learning / Q000187:drug effects; D008568:Memory / Q000187:drug effects; D020521:Stroke / Q000188:drug therapy; D009435:Synaptic Transmission / Q000187:drug effects
chemical_list: D003566:Cytidine Diphosphate Choline